A Diagnostics & Imaging Week
SeraCare Life Sciences (Oceanside, California) reported that it has closed its previously announced acquisition of the Milford, Massachusetts, diagnostic manufacturing facilities and product lines of the Celliance subsidiary of Serologicals (both Atlanta).
"We are pleased to have completed this acquisition as we expect it will increase our portfolio of products in the areas of molecular diagnostic reagents, diagnostic intermediates and substrates," said Michael Crowley Jr., president and CEO of SeraCare. "In connection with this acquisition, we have assumed the lease on Celliance's state of the art manufacturing, storage and distribution facility located near our West Bridgewater manufacturing site. We believe the proximity of these two diagnostic manufacturing facilities will allow us to achieve synergies in the areas of manufacturing, staffing and distribution."
SeraCare is a manufacturer of biological products and services to diagnostic, therapeutic, drug discovery and research organizations.